iTind BPH treatment in Canada

BPH treatment is now available in Canada — but it may not be the best choice for all patients. Learn how to properly diagnose and treat this common condition with the help of a professional.

CENTER VALLEY, PA — Urologic surgeon Jonathan Warner, MD, of Emanate Health Foothill Presbyterian Hospital in Glendora, CA, and Kenneth Kernen, MD, Chief of Urology at Beaumont Health in Michigan were among the first physicians to treat patients with iTind, Olympus’ new minimally invasive treatment for Benign Prostatic Hyperplasia (BPH). iTind is a non-surgical procedure for treating enlarged prostates (BPH) that doesn’t require a permanent implant or heating or removal of prostate tissue. It’s been shown to improve lower urinary tract symptoms (LUTS) and quality of life, while preserving erectile function and urinary flow in clinical trials. URL

The system impact

iTind is a relatively simple device that can be used in an outpatient setting to avoid the need for a theatre, general anaesthetics or an overnight stay. This would free up space in the urology department, reduce pressure on inpatient beds, and potentially lead to shorter waiting times. It also doesn’t rely on capital equipment and can be used by urologists with a limited level of training. As a result, it can be delivered quickly and at low cost. It is a potential alternative to TURP or other ablative therapies, such as Rezum water vapour therapy and Greenlight XPS. iTind has been shown to have similar efficacy and safety to these other treatments.

Leave a Reply

Your email address will not be published. Required fields are marked *

Follow by Email